小剂量胰高血糖素预防1型糖尿病运动诱发性低血糖
一项四阶段随机交叉试验纳入15例使用持续皮下胰岛素输注的1型糖尿病成人,比较无干预、基础胰岛素减量50%、口服40克葡萄糖片或皮下注射150微克小剂量胰高血糖素对晨间空腹运动后血糖的影响。结果显示小剂量胰高血糖素可能比减少胰岛素更有效预防运动诱发性低血糖,且比摄入碳水化合物导致更少的干预后高血糖。
要点
- 小剂量胰高血糖素组运动及早期恢复期血糖轻度升高,而对照组和胰岛素减量组血糖下降。
- 低血糖(血糖<70 mg/dL)发生在对照组6例、胰岛素减量组5例,葡萄糖片组和小剂量胰高血糖素组均为0例。
- 高血糖(血糖≥250 mg/dL)发生在葡萄糖片组5例、小剂量胰高血糖素组1例。
核心结论
- 小剂量胰高血糖素可能比减少胰岛素更有效预防运动诱发性低血糖,且可能比摄入碳水化合物导致更少的干预后高血糖。
研究设计与样本
- 四阶段随机交叉试验,纳入15例使用持续皮下胰岛素输注的1型糖尿病成人,晨间空腹以约55%最大摄氧量运动45分钟。
主要发现
- 运动及早期恢复期,小剂量胰高血糖素组血浆葡萄糖轻度升高,对照组和胰岛素减量组下降,葡萄糖片组升高更明显(P < 0.001)。
- 各阶段胰岛素水平无差异,小剂量胰高血糖素组胰高血糖素升高(P < 0.001)。
- 低血糖(血浆葡萄糖<70 mg/dL)发生在对照组6例、胰岛素减量组5例,葡萄糖片组和小剂量胰高血糖素组均为0例。
- 高血糖(血浆葡萄糖≥250 mg/dL)发生在葡萄糖片组5例、小剂量胰高血糖素组1例。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Patients with type 1 diabetes who do aerobic exercise often experience a drop in blood glucose concentration that can result in hypoglycemia. Current approaches to prevent exercise-induced hypoglycemia include reduction in insulin dose or ingestion of carbohydrates, but these strategies may still result in hypoglycemia or hyperglycemia. We sought to determine whether mini-dose glucagon (MDG) given subcutaneously before exercise could prevent subsequent glucose lowering and to compare the glycemic response to current approaches for mitigating exercise-associated hypoglycemia. RESEARCH DESIGN AND METHODS: We conducted a four-session, randomized crossover trial involving 15 adults with type 1 diabetes treated with continuous subcutaneous insulin infusion who exercised fasting in the morning at ∼55% VO2max for 45 min under conditions of no intervention (control), 50% basal insulin reduction, 40-g oral glucose tablets, or 150-μg subcutaneous glucagon (MDG). RESULTS: During exercise and early recovery from exercise, plasma glucose increased slightly with MDG compared with a decrease with control and insulin reduction and a greater increase with glucose tablets (P < 0.001). Insulin levels were not different among sessions, whereas glucagon increased with MDG administration (P < 0.001). Hypoglycemia (plasma glucose <70 mg/dL) was experienced by six subjects during control, five subjects during insulin reduction, and none with glucose tablets or MDG; five subjects experienced hyperglycemia (plasma glucose ≥250 mg/dL) with glucose tablets and one with MDG. CONCLUSIONS: MDG may be more effective than insulin reduction for preventing exercise-induced hypoglycemia and may result in less postintervention hyperglycemia than ingestion of carbohydrate.
引用
- Rickels MR, DuBose SN, Toschi E, et al. Mini-Dose Glucagon as a Novel Approach to Prevent Exercise-Induced Hypoglycemia in Type 1 Diabetes. Diabetes Care. 2018. PMID: 29776987. doi:10.2337/dc18-0051
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。